A clinical trial to find out the efficacy of the Siddha drug Sathakuppai Chooranam in patients with Polycystic Ovarian Syndrome

Phase II Non-randomized open clinical evaluation of siddha drug Sathakuppai chooranam for Soothaga vaayu(PCOS) in women of age between 15 and 35 years attending OPD at AAGHIM attached with GSMC

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/08/020859

Enrollment

Registered

2019-08-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Sathakuppai chooranam: 5 grams of Sathakuppai chooranam is administered twice a day for 90 days Control Intervention1: NIL: NIL Control Intervention2: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Female between 15 and 35 years Unmarried and married women Married women with primary infertility Amenorrhoea Irregular menstruation Ovulation related infertility Oligomenorrhoea Polycystic ovary in ultra sound(unilateral/bilateral)

Exclusion criteria

Exclusion criteria: H/O Hyperthyroidism/Hypothyroidism H/O Congenital uterine defects H/O Pituitary/Adrenal disorders H/O Hemorrhagic cyst H/O Chocolate cyst H/O Any serious systemic illness H/O Tuberculosis of the ovary and uterus Will be excluded clinically or based on the available medical reports

Design outcomes

Primary

Measure	Time frame
Regulation of menstrual cycle Regulation of hormonal profile Regulation of ovulation Disappearance/reduction in the size or number of the cystTimepoint: 90 days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Sathya Priyanka PM

Government Siddha Medical College

rangasamymenaka75@gmail.com9444669661

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026